Phraction Management LLC Lowers Stock Position in Lam Research Corporation $LRCX

Phraction Management LLC trimmed its stake in Lam Research Corporation (NASDAQ:LRCXFree Report) by 28.2% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 15,774 shares of the semiconductor company’s stock after selling 6,200 shares during the period. Lam Research comprises 1.1% of Phraction Management LLC’s investment portfolio, making the stock its 25th biggest holding. Phraction Management LLC’s holdings in Lam Research were worth $6,835,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Norges Bank acquired a new position in Lam Research during the fourth quarter worth $3,645,427,000. Price T Rowe Associates Inc. MD raised its holdings in shares of Lam Research by 352.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock valued at $2,344,347,000 after buying an additional 10,666,540 shares during the period. Franklin Resources Inc. raised its holdings in shares of Lam Research by 57.0% in the 4th quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock valued at $1,730,724,000 after buying an additional 3,671,073 shares during the period. Corient Private Wealth LLC lifted its stake in Lam Research by 235.5% during the 4th quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock worth $890,040,000 after acquiring an additional 3,649,553 shares in the last quarter. Finally, J. Stern & Co. LLP lifted its stake in Lam Research by 3,826.9% during the 4th quarter. J. Stern & Co. LLP now owns 3,459,377 shares of the semiconductor company’s stock worth $592,176,000 after acquiring an additional 3,371,283 shares in the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research Trading Down 4.6%

NASDAQ:LRCX opened at $327.92 on Wednesday. The stock has a 50-day simple moving average of $339.86 and a 200-day simple moving average of $284.93. The stock has a market cap of $410.33 billion, a P/E ratio of 56.93, a P/E/G ratio of 1.32 and a beta of 1.84. Lam Research Corporation has a 1 year low of $94.11 and a 1 year high of $438.50. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63.

Lam Research (NASDAQ:LRCXGet Free Report) last issued its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.69 by $0.13. The business had revenue of $6.72 billion for the quarter, compared to analyst estimates of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The business’s quarterly revenue was up 30.0% on a year-over-year basis. During the same quarter last year, the company earned $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, analysts anticipate that Lam Research Corporation will post 9.32 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, Director Eric Brandt sold 54,500 shares of the business’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the sale, the director owned 199,205 shares in the company, valued at approximately $69,881,114. The trade was a 21.48% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the company’s stock in a transaction on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the completion of the transaction, the director owned 87,142 shares of the company’s stock, valued at approximately $29,192,570. The trade was a 17.34% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 80,441 shares of company stock valued at $27,614,296. 0.31% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on LRCX shares. Seaport Research Partners started coverage on Lam Research in a research report on Monday, May 4th. They issued a “buy” rating and a $300.00 target price for the company. Mizuho raised their price objective on shares of Lam Research from $380.00 to $400.00 and gave the company an “outperform” rating in a research note on Thursday, July 9th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $350.00 target price (down from $450.00) on shares of Lam Research in a research note on Thursday, July 30th. Sanford C. Bernstein increased their target price on shares of Lam Research from $325.00 to $340.00 and gave the stock an “outperform” rating in a report on Thursday, May 21st. Finally, Morgan Stanley decreased their price target on shares of Lam Research from $404.00 to $367.00 and set an “overweight” rating for the company in a research report on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $358.47.

Get Our Latest Report on LRCX

About Lam Research

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Recommended Stories

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.